Syntekabio Suggests Potential of AI-Based Toxicity Prediction for Carcinogenic Risk Assessment 송영두 2026.03.23 오후 12:17 Syntekabio Clears Delisting Risk with Unqualified Audit Opinion 송영두 2026.03.20 오전 08:17 SyntekaBio Enters ‘Assetization Phase’ for AI Asset Program 송영두 2026.01.21 오전 09:27 Syntekabio Showcases AI Drug Platform at Interbiz 2025 송영두 2025.07.07 오후 02:53 Syntekabio Leads AI Datacenter Shift with Eco-Friendly Natural Convection 송영두 2025.07.21 오전 10:26 Syntekabio Expands Global Contracts, Boosts Growth with Next-Gen AI Platforms 송영두 2025.08.27 오후 05:34 ABL Bio Boosts Tech Export Potential Amid Big Deal, Biotech Demand Soars[K-bio Pulse] 김새미 2025.11.12 오후 06:05 신테카바이오, AI 신약개발 플랫폼 특허 추가 취득 송영두 2025.01.22 오전 09:40 Syntekabio wins SI deal from HYBE’s Weverse unit 나은경 2025.12.17 오후 01:42 SyntekaBio, Panolos Sign MOU on Next-Gen Multispecific Antibodies 송영두 2025.12.05 오전 09:55 더 보기 로딩중..
Syntekabio
Syntekabio
![ABL Bio Boosts Tech Export Potential Amid Big Deal, Biotech Demand Soars[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/11/PS25111201284b.jpg)
